Marketing (Health)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Product Launches
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Launches
OTC Marketing Awards 2022: What The Judges Said About The Leading Entries
The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?
Haleon Voted Company Of The Year At The OTC Marketing Awards 2022
Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.
Bayer Extends Afrin Line With First OTC Oxymetazoline Spray In US For Children Under 6
Children’s Afrin regular and no-drip formulations reach US stores with consumers having choices between dozens of oxymetazoline nasal sprays available under an FDA OTC monograph. But products indicated for children was limited to one, Mucinex Childrens Stuffy Nose, and it’s for children 6 and up.
Advertising Campaigns
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Ad Campaigns
OTC Marketing Awards 2022: What The Judges Said About The Leading Entries
The trophies have been handed out at the OTC Marketing Awards 2022 - but what did the expert judges have to say about the winning and highly-commended entries?
Haleon Voted Company Of The Year At The OTC Marketing Awards 2022
Winners across 15 categories were announced at the OTC Marketing Awards 2022 on 28 November, with Haleon crowned OTC Company of the Year.
UK Pharmacies Recommending Short-Term Treatments Over PPIs For Frequent Heartburn – Haleon Survey
Haleon data shows a notable increase in UK pharmacy teams recommending PPIs for frequent heartburn in the year ended September 2022. However, pharmacies are still recommending alginate-based OTCs and antacids over PPIs for frequent heartburn in the majority of occasions, which Haleon says points to a need for more pharmacy education.
Advertising Enforcement
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Ad Complaints
On J&J Challenge, Review Finds Nothing Funny In Genexa’s ‘Real Ingredients’ Comparison To Tylenol
Genexa appeals NAD recommendations to stop using or modify claims that make up the core of its advertising to differentiate its products. NAD reviewed ad claims for Genexa kids’ Pain & Fever acetaminophen product on a challenge by J&J.
Genexa Continues ‘Clean Medicine’ Mission With Guafenesin For Adults Launch
Launch comes six months after Genexa launched Acetaminophen Extra Strength and Acetaminophen PM caplets with “same active ingredients and dosages of current category leaders but without artificial dyes, synthetic fillers and other artificial preservatives,” and seven months after it was named to Fast Company’s annual list of the World’s Most Innovative Companies for 2022.
Perrigo's Evidence For Nasal Spray Claims Not Enough For ASA
Ad claims that Perrigo’s BecoCleanse could protect against viruses to help prevent the occurrence of cold symptoms were not supported by sufficient evidence, the UK’s Advertising Standards Authority has ruled.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.